Chris@CNW, Author at CannabisNewsWire

TuesdayOct 17, 2023 4:20 am

420 with CNW — International Report Says Drug War Compromises Efforts to Attain Environmental Justice, Fight Climate Change

An international coalition of advocacy groups has released a report outlining how the global war against drugs has compromised efforts to deal with the climate crisis and accelerated the environmental destruction of crucial ecosystems across the world. While the initial days of the drug war are long gone, especially in nations such as the United States, Canada and Australia, which are now embracing drug reform, its harmful effects are still felt in many facets of society. One of the most dire results of the drug war was almost unparalleled growth in the illicit drug market that has significantly contributed to…

MondayOct 16, 2023 4:20 pm

420 with CNW — Study Reveals No Major Change in Youth Cannabis Use Following Legalization in Canada

A recent study, featured in the JAMA Open Network, has shed light on the impact of marijuana legalization in Canada, specifically concerning its effects on young individuals and potential adverse consequences. The research, conducted in Ontario, focused on a cohort of young adults aged between 19.5 to 23 years, aiming to understand changes in marijuana consumption patterns and related outcomes. Over the span of three years, from February 2017 to February 2020, the researchers conducted surveys every four months, collecting data that encompassed both the pre- and post-legalization periods. The study involved 619 participants, with an average age of 21…

MondayOct 16, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs

Lexaria recently announced its intention to launch new human and animal studies exploring its patented DehydraTECH(TM) technology on GLP-1 drugs for the potential treatment of diabetes The studies will build on what Lexaria has achieved so far since it started its diabetes-related studies in 2022 Its DehydraTECH-CBD demonstrated an almost three-fold improvement in drug delivery into the blood in its DIAB-A22-1 diabetes study compared to the DehydraTECH-CBD formulation used in its HYPER-H21-4 hypertension study These studies follow Lexaria’s announcement of its intention to study weight loss and diabetes control in a human population using DehydraTECH Lexaria Bioscience (NASDAQ: LEXX), a…

MondayOct 16, 2023 4:20 am

420 with CNW — Georgia State Residents Could Soon Access Medical Cannabis in Pharmacies

Officials in Georgia recently announced that the state would begin to provide medical cannabis products in pharmacies statewide. Last week, the state’s pharmacy board started accepting applications for independent pharmacies that wanted to take part in the exercise. Once applications have been submitted, all pharmacies will have to undergo inspection before they can receive approval from the board. Thus far, almost 120 drugstores have agreed to provide drugs from Botanical Sciences, one of the licensed production companies in the state. It is expected that it will take a couple of weeks before medical cannabis is available in pharmacies. At the…

FridayOct 13, 2023 4:20 pm

420 with CNW — DOJ Defends Ban on Gun Rights of Medical Cannabis Users in Federal Appeals Court

A federal court of appeals recently held oral arguments in a case addressing the constitutionality of the federal ban that prevents medical cannabis patients from buying or owning firearms. The proceedings unfolded before a three-judge panel of the U.S. 11th Circuit Court of Appeals, where lawyers representing the Justice Department and Florida's medical marijuana patients presented their respective arguments. The case has been extensively discussed through numerous briefings spanning over a year. The plaintiffs’ attorney, Will Hall, outlined two key reasons supporting the federal ban’s unconstitutionality. Firstly, Hall argued that regardless of whether marijuana usage is lawful, committing a crime…

FridayOct 13, 2023 4:20 am

420 with CNW — Advocates, Lawmakers Push Biden for More Action as His Mass Pardons Order Reaches Year Mark

One year after President Joe Biden ordered a mass cannabis pardon and called for a review of marijuana’s status at the federal level, advocates and lawmakers are pushing for more marijuana action. President Biden based part of his campaign on cannabis reform and pledged to do things such as pardon Americans with cannabis-related convictions, something his administration set out to do a year ago. However, cannabis advocates and lawmakers have long argued that the administration could do more to further cannabis reform in the country, calling on the Biden administration to fulfill its cannabis promises in full and on time.…

ThursdayOct 12, 2023 4:20 pm

420 with CNW — Mismatch Grows Between the Public’s Interest In, Education About Cannabis

Public perceptions about cannabis have come a long way over the past couple of decades. For the generations that grew up during the war on drugs era, cannabis was framed as a dangerous illicit drug that acted as a gateway to more hardcore drug use and increased criminal activity in communities. However, as states such as California began legalizing cannabis for medical use over two decades ago and state-level cannabis criminalization steadily reduced, attitudes toward cannabis across the country began to improve. These days, most nationwide polls show that the majority of the country is in favor of legalizing medical…

ThursdayOct 12, 2023 4:20 am

420 with CNW — Marijuana Testing Scrutinized as Product Recalls, Differing Rules Draw Attention

State cannabis authorities, producers and various stakeholders are currently contending with the challenge of ensuring consumer safety in an environment where lab-testing regulations and enforcement practices vary widely across the nation, resulting in frequent large-scale product recalls. At present, each state adopts its own approach to conducting lab tests for both medical and recreational cannabis, assessing inspections, potency, contaminants and production standards. This fragmented approach has led to inconsistent regulations for testing and raised concerns about whether safeguarding consumers truly ranks as a top priority for industry players. Americans for Safe Access (ASA) founder Steph Sherer attributes this patchwork approach…

WednesdayOct 11, 2023 4:20 pm

420 with CNW — Study Finds Entourage Effect of Marijuana Triggers More Intense High Than THC Alone

When many people contemplate the euphoria induced by marijuana consumption, their thoughts inevitably gravitate toward THC, the plant's principal psychoactive constituent. However, a recent study lends support to the notion of the “entourage effect,” demonstrating that marijuana products containing a wider variety of natural cannabinoids result in an even more potent psychoactive high than those made from pure THC. This research used innovative electroencephalogram (EEG) technology, augmented by AI capabilities, to gauge the euphoria that individuals experienced while vaporizing two distinct products. The first was a full-spectrum live rosin with an average concentration of 85% THC, complemented by other natural…

WednesdayOct 11, 2023 4:20 am

420 with CNW — Florida Supreme Court Sets Date to Decide Cannabis Ballot Measure’s Fate

The Florida Supreme Court has set dates for oral arguments in a case that will determine if a state cannabis legalization measure appears on the 2024 ballot. Both the Smart & Safe Florida campaign, which sponsored the cannabis legalization proposal, and the state attorney general have spent the past few months sending briefs to Florida’s Supreme Court. Florida Attorney General Ashley Moody filed a challenge against the proposal and called for its invalidation on the grounds that it is misleading. She argued in her challenge that the measure was ‘”effectively misleading” because it doesn’t explicitly state that marijuana will still…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Author: Chris@CNW